Holen Sie sich die Stockscreener-App
23.25
0.21%
0.0485
Handel nachbörslich:
23.46
0.2059
+0.89%
Schlusskurs vom Vortag:
$23.21
Offen:
$23.1087
24-Stunden-Volumen:
4,865
Relative Volume:
0.43
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.73%
1M Leistung:
+4.47%
6M Leistung:
+2.99%
1J Leistung:
-0.84%
1-Tages-Spanne:
$23.11
$23.27
1-Wochen-Bereich:
$22.25
$23.27
52-Wochen-Spanne:
$17.84
$24.84
Invesco Nasdaq Biotechnology Etf Stock (IBBQ) Company Profile
Firmenname
Invesco Nasdaq Biotechnology Etf
Sektor
Branche
Telefon
404-892-0896
Adresse
1331 SPRING STREET NW, ATLANTA
Vergleichen Sie IBBQ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBBQ
Invesco Nasdaq Biotechnology Etf
|
23.25 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
317.19 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.95 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.13 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
246.88 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
579.89 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Nasdaq Biotechnology Etf Aktie (IBBQ) Neueste Nachrichten
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Vertex Pharmaceuticals Plunges 2.69%—Is This the Bottom for Vertex Pharmaceuticals? - AInvest
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Invesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.02870 - MSN
Billionaires Are Buying a Popular AI Index Fund That Could Turn $500 Per Month Into $432,300 - The Globe and Mail
Cetera Investment Advisers Sells 2,062 Shares of Invesco High Yield Equity Dividend Achievers ETF (NASDAQ:PEY) - Defense World
Cetera Investment Advisers Buys Shares of 159,532 Invesco S&P Global Water Index ETF (NYSEARCA:CGW) - Defense World
Invesco CEF Income Composite ETF (NYSEARCA:PCEF) Stake Boosted by IFP Advisors Inc - Defense World
Cetera Investment Advisers Increases Stake in Invesco CEF Income Composite ETF (NYSEARCA:PCEF) - Defense World
Invesco Aerospace & Defense ETF (NYSEARCA:PPA) Shares Sold by Picton Mahoney Asset Management - Defense World
Invesco MSCI Global Timber ETF (NYSEARCA:CUT) Sees Significant Decline in Short Interest - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Wealthquest Corp Takes $1.54 Million Position in Curis, Inc. (NASDAQ:CRIS) - Defense World
N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Sold by Norden Group LLC - Defense World
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Acquired by Bank of New York Mellon Corp - Defense World
J.W. Cole Advisors Inc. Acquires Shares of 55,467 Invesco Senior Loan ETF (NYSEARCA:BKLN) - Defense World
TD Cowen Calls QQQ Restructure a Game Changer for Invesco Earnings - Investing.com
6 Best Health Care Funds and ETFs for 2025 - US News Money
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Envestnet Asset Management Inc. Has $9.16 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
Invesco PHLX Semiconductor ETF SOXQ Q2 2025 Earnings Preview Upside Potential Amid Strong Semiconductor Sector Growth - AInvest
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco KBW Bank ETF KBWB Q2 2025 Earnings Preview Upside Potential on Robust Bank Sector Performance - AInvest
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - MSN
Viatris' Strategic Resilience Amid Clinical Setbacks: Diversification as a Path to Ophthalmology Growth - AInvest
ETF Pulse Check Navigating the Challenges of FTXG - AInvest
ETF Pulse Check Navigating the Challenges of the Invesco Nasdaq Biotechnology ETF - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
(IBBQ) Investment Analysis and Advice - news.stocktradersdaily.com
VTI Adds $1.6B in Assets as S&P 500 Hits New Record High - TradingView
Vir Biotechnology (NASDAQ:VIR) Upgraded at Raymond James Financial - Defense World
RSV Threat Rises – Are These Biotechs Ready to Save the Day? - AInvest
INVESCO MORTGAGE CAPITAL (NYSE:IVR) Stock Price Expected to Rise, UBS Group Analyst Says - Defense World
Moderna Stock Slumps 187% in Trading Volume Ranking 408th - AInvest
SA Quant's top healthcare picks amid Q2 earnings season - Seeking Alpha
Private Trust Co. NA Purchases 369 Shares of Invesco Large Cap Value ETF (NYSEARCA:PWV) - Defense World
Private Trust Co. NA Acquires 893 Shares of Invesco National AMT-Free Municipal Bond ETF (NYSEARCA:PZA) - Defense World
Tonix Pharmaceuticals' TNX-102 SL: A Breakthrough in Fibromyalgia Treatment and Its Implications for Investors - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
Invesco S&P 500 Equal Weight Energy ETF (NYSEARCA:RSPG) Shares Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Viatris' MR-141: A Vision for Dominance in the Presbyopia Market - AInvest
Learn to Evaluate (IBBQ) using the Charts - news.stocktradersdaily.com
Finanzdaten der Invesco Nasdaq Biotechnology Etf-Aktie (IBBQ)
Es liegen keine Finanzdaten für Invesco Nasdaq Biotechnology Etf (IBBQ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):